← Open Payments lookup

PETER MARLIN: Open Payments

NPI 1982694683 · COLORADO SPRINGS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,044 in 40 payments from 14 companies in 2025. Trend: 2023 $309 · 2024 $1,120 · 2025 $1,044

Food & beverage: $1,044
CompanyPaymentsAmount
Alkermes, Inc.6$226
E.R. Squibb & Sons, L.L.C.5$176
Teva Pharmaceuticals USA, Inc.7$138
Neurocrine BioSciences, Inc.3$104
Otsuka America Pharmaceutical, Inc.5$99
ABBVIE INC.2$67
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$63
Lundbeck LLC2$41
Takeda Pharmaceuticals U.S.A., Inc.2$38
Boehringer Ingelheim Pharmaceuticals, Inc.1$23

Products named: ARISTADA, COBENFY, AUSTEDO XR, INGREZZA, REXULTI, VRAYLAR, CAPLYTA, VIVITROL.

Industry payments across CO — which companies pay providers there.